Mutations in ATM, MGA, KMT2A, MLLT10, NSD1, and TET2 have been commonly identified in several hematological neoplasms, including both acute lymphoid and myeloid leukemia [27,28]. This evidence concerns the gene ATM and hematopoietic and lymphoid system neoplasm.